Effects of ethyl pyruvate on cardiac function recovery and apoptosis reduction after global cold ischemia and reperfusion

Experimental and Therapeutic Medicine

Volumn 7, Issue 5, 2014, Pages 1197-1202

  Guo, Jialong ^a   Zhang, Jun ^a   Luo, Xiangyu ^a   Luo, Weimin ^a   Lin, Chengyi ^a   Zhang, Kailun ^b   Ji, Yanmei ^a  

^a Taihe Hospital Affiliated to Hubei Medical College   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Ethyl pyruvate; Heart; Rat; Transplantation

Indexed keywords

ADENOSINE TRIPHOSPHATE; DNA NUCLEOTIDYLEXOTRANSFERASE; MALONALDEHYDE; PROTEINASE; PYRUVIC ACID; PYRUVIC ACID ETHYL ESTER; UNCLASSIFIED DRUG;

ADULT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART RATE; HEMODYNAMIC PARAMETERS; MALE; NICK END LABELING; NONHUMAN; RAT; REPERFUSION INJURY; SPECTROPHOTOMETER; THERAPY EFFECT;

EID: 84896848320     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1581     Document Type: Article

References (31)

1. Stringham JC, Southard JH, Hegge J, Triemstra L, FieldsBL and BelzerFO: Limitations of heart preservation by cold storage. Transplantation53: 287-294, 1992.
2. Frank A, Bonney M, Bonney S, et al: Myocardial ischemia reperfusion injury: from basic science to clinical bedside. Semin Cardiothorac Vasc Anesth 16: 123-132, 2012.
3. Jang IS, Park MY, Shin IW, Sohn JT, Lee HK and ChungYK: Ethyl pyruvate has anti-inflammatory and delayed myocardial protective effects after regional ischemia/reperfusion injury. Yonsei Med J51: 838-844, 2010.
4. Guo J, Zhang K, Ji Y, et al: Effects of ethyl pyruvate on myocardial apoptosis and expression of Bcl-2 and Bax proteins after ischemia-reperfusion in rats. J Huazhong Univ Sci Technolog Med Sci28: 281-283, 2008.
5. Hu X, Cui B, Zhou X, et al: Ethyl pyruvate reduces myocardial ischemia and reperfusion injury by inhibiting high mobility group box1 protein in rats. Mol Biol Rep39: 227-231, 2012.
6. Jahania MS, Sanchez JA, Narayan P, Lasley RD and MentzerRMJr: Heart preservation for transplantation: principles and strategies. Ann Thorac Surg68: 1983-1987, 1999.
7. DeBoer LW, Bekx PA, Han L and Steinke L: Pyruvate enhances recovery of rat hearts after ischemia and reperfusion by preventing free radical generation. Am J Physiol265: H1571-H1576, 1993.
8. Manthorpe M, Cornefert-Jensen F, Hartikka J, FelgnerJ, RundellA, Margalith M and Dwarki V: Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum Gene Ther4: 419-431, 1993.
9. Stanley PE: Extraction of adenosine triphosphate from microbial and somatic cells. Methods Enzymol133: 14-22, 1986.
10. Yagi K: A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med15: 212-216, 1976.
11. Ochiai K, Zhang J, Gong G, Zhang Y, Liu J, Ye Y, Wu X, LiuH, MurakamiY, Bache RJ, Ugurbil K and From AH: Effects of augmented delivery of pyruvate on myocardial high-energy phosphate metabolism at high workstate. Am J Physiol Heart Circ Physiol281: H1823-H1832, 2001.
12. Mallet RT: Pyruvate: metabolic protector of cardiac performance. Proc Soc Exp Biol Med223: 136-148, 2000.
13. Olivencia-Yurvati AH, Blair JL, Baig M and MalletRT: Pyruvate-enhanced cardioprotection during surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth17: 715-720, 2003.
14. Fink MP: Ethyl pyruvate: a novel anti-inflammatory agent. J Intern Med261: 349-362, 2007.
15. Mallet RT, Sun J, Knott EM, Sharma AB and Olivencia-YurvatiAH: Metabolic cardioprotection by pyruvate: recent progress. Exp Biol Med (Maywood) 230: 435-443, 2005.
16. Aneja R and Fink MP: Promising therapeutic agents for sepsis. Trends Microbiol15: 31-37, 2007.
17. Cruz RJ Jr, Harada T, Sasatomi E and Fink MP: Effects of ethyl pyruvate and other α-keto carboxylic acid derivatives in a rat model of multivisceral ischemia and reperfusion. J Surg Res165: 151-157, 2011.
18. Wang Y, Li B, Li Z, Huang S, Wang J and Sun R: Improvement of hypoxia-ischemia-induced white matter injury in immature rat brain by ethyl pyruvate. Neurochem Res38: 742-752, 2013.
19. Kung CW, Lee YM, Cheng PY, Peng YJ and YenMH: Ethyl pyruvate reduces acute lung injury via regulation of iNOS and HO-1 expression in endotoxemic rats. J Surg Res167: 323-331, 2011.
20. Akkoc H, Kelle I, Tunik S, Bahceci S, Sencar L, Ayaz E, NergizY, Erdinc L and Erdinc M: Protective effect of ethyl pyruvate on liver injury in streptozotocin-induced diabetic rats. Acta Gastroenterol Belg75: 336-341, 2012.
21. Han Y, Englert JA, Yang R, Delude RL and Fink MP: Ethyl pyruvate inhibits nuclear factor-kappaB-dependent signaling by directly targeting p65. J Pharmacol Exp Ther312: 1097-1105, 2005.
22. Uchiyama T, Delude RL and Fink MP: Dose-dependent effects of ethyl pyruvate in mice subjected to mesenteric ischemia and reperfusion. Intensive Care Med 29: 2050-2058, 1992.
23. Raedschelders K, Ansley DM and Chen DD: The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion. Pharmacol Ther 133: 230-255, 2012.
24. Kao KK and Fink MP: The biochemical basis for the anti-inflammatory and cytoprotective actions of ethyl pyruvate and related compounds. Biochem Pharmacol 80: 151-159, 2010.
25. Fink MP: Ethyl pyruvate. Curr Opin Anaesthesiol 21: 160-167, 2008.
26. Sinha K, Das J, Pal PB and Sil PC: Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch Toxicol87: 1157-1180, 2013.
27. Handy DE and Loscalzo J: Redox regulation of mitochondrial function. Antioxid Redox Signal16: 1323-1367, 2012.
28. Frank A, Bonney M, Bonney S, Weitzel L, Koeppen M and EckleT: Myocardial ischemia reperfusion injury: from basic science to clinical bedside. Semin Cardiothorac Vasc Anesth16: 123-132, 2012.
29. Dobsák P, Siegelova J, Wolf JE, Rochette L, EicherJC, VaskuJ, KuchtickovaS and Horky M: Prevention of apoptosis by deferoxamine during 4hours of cold cardioplegia and reperfusion: in vitro study of isolated working rat heart model. Pathophysiology9: 27, 2002.
30. Yue TL, Ma XL, Wang X, Romanic AM, Liu GL, LoudenC, GuJL, Kumar S, Poste G, Ruffolo RR Jr and FeuersteinGZ: Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ Res82: 166-74, 1998.
31. Martin BJ, Valdivia HH, Bünger R, Lasley RD and MentzerRMJr: Pyruvate augments calcium transients and cell shortening in rat ventricular myocytes. Am J Physiol274: H8-H17, 1998.